FDA.reportPublic FDA data

Application 761099

Type
BLA
Sponsor
PFIZER INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZIRABEVBEVACIZUMAB-BVZRINJECTABLE;INJECTION100MG/4MLNoNo
002ZIRABEVBEVACIZUMAB-BVZRINJECTABLE;INJECTION400MG/16MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0069-0315Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0315Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0315Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0315Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0315Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0342Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0342Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0342Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0342Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent
0069-0342Zirabevbevacizumab-bvzrPfizer Laboratories Div Pfizer IncBLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79506SUPPL 2024-08-29
79505SUPPL 2024-08-29
73586SUPPL 2023-02-22
73553SUPPL 2023-02-17
66222SUPPL2021-02-16
66221SUPPL2021-02-16
66172SUPPL2021-02-10
59703ORIG2019-08-14
59196ORIG2019-06-28
59190ORIG2019-06-28